TITLE

Comparación clínica de alfa dihidroergocriptina contra cabergolina en el tratamiento de la mastopatía fibroquística

AUTHOR(S)
Castillo-Huerta, Eugenio; Garibay-Valencia, Miguel; Mirabent-González, Felio
PUB. DATE
July 2013
SOURCE
Ginecologia y Obstetricia de Mexico;Jul2013, Vol. 81 Issue 7, p370
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Fibrocystic breast disease is one of the most frequent conditions of the breast among women from 30 to 49 years, with a frequency of about 60%, hence the interest in studying and treating it with the most advanced and effective resources. Objective: To compare the efficacy and adverse events of alpha dihydroergocryptine with cabergoline in patients with fibrocystic breast disease. Material and Methods: A prospective, longitudinal, open, comparative study between alpha-dihydroergocryptine and cabergoline, made in the service of Gynecology and Obstetrics at the Dr. Miguel Silva General Hospital in Morelia, Michoacán. 171 patients diagnosed with fibrocystic breast disease were randomly assigned to the alpha-dihydroergocryptine or the cabergoline group. Assessments were made at baseline and every month subsequently. The following symptoms were evaluated: breast tenderness, breast pain, lumps and nipple discharge. The concentrations of prolactin were determined and an ultrasound was performed at baseline and at 3 and 6 months, patients were questioned about adverse events. Results: 171 patients were included (81 treated with alpha-dihydroergocryptine and 90 with cabergoline); 156 completed the study. The age limits were 18 and 51 years. The evolution time prior to study entry was 17.71 ± 18.3 months for the alpha-dihydroergocryptine group and 18.57 ± 20.35 for the cabergoline group. 15 patients discontinued treatment due to adverse events (8 of the alpha-dihydroergocryptine group and 7 of the cabergoline group). The most common adverse event was headache. Conclusions: In this study alpha-dihydroergocryptine was better tolerated and had better clinical response compared with cabergoline; breast pain and breast tenderness disappeared within the first month of treatment. Adverse events were similar for both treatments.
ACCESSION #
89915151

 

Related Articles

  • Giant Fibroadenomatoid Hyperplasia of the Breast: A Case Report. Zhang, Hao; Wang, Xin-Lu; Ren, Wei-Dong; Shi, Tie-Mei // Gynecologic & Obstetric Investigation;Feb2014, Vol. 77 Issue 2, p134 

    Fibroadenomatoid hyperplasia of the breast (FAHB) is a rare benign breast lesion and its clinical features are similar to fibroadenoma and fibrocystic changes. FAHB has been previously termed sclerosing lobular hyperplasia, fibroadenomatosis, fibroadenomatoid change, or fibroadenomatoid...

  • Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity. Oiwa, Mikinao; Endo, Tokiko; Ichihara, Shu; Moritani, Suzuko; Hasegawa, Masaki; Iwakoshi, Akari; Sato, Yasuyuki; Morita, Takako; Hayashi, Takako; Kato, Aya // Virchows Archiv;Jul2015, Vol. 467 Issue 1, p71 

    Breast cancer is occasionally complicated by sclerosing adenosis (SA). Although both lesions usually originate in the terminal duct lobular unit, their pathogenetic relationship has not yet been elucidated. The present study analyzed 63 breast cancer patients with SA (involving a total of 75...

  • Fibrocystic Breast Condition.  // Diseases & Disorders: A Nursing Therapeutics Manual, 2nd edition;2002, p368 

    Offers information on fibrocystic breast condition, the most common type of benign breast disorder. Causes of the condition; Gender and life span considerations; Signs and symptoms of the disease; Primary nursing diagnosis; Planning and implementation of treatment.

  • Understanding benign breast conditions. Graham, Helen // Practice Nurse;7/28/2006, Vol. 32 Issue 2, p29 

    The article presents information on benign breast conditions. Until recently benign breast disease was an umbrella term given to a wide range of common conditions of the breast, which were often referred to as fibrocystic disease, fibrocystic change or cystic disease. Many women seek advice for...

  • Fibrocystic Breast Condition.  // Diseases & Disorders: A Nursing Therapeutics Manual, 3rd edition;2007, p348 

    The article presents a nursing guide to fibrocystic breast condition. It discusses the causes, assessment, diagnosis and treatment of the disease. It describes the genetic, racial and ethnic characteristics of the people most susceptible to this disease. Guidelines for independent nursing...

  • FIBROCYSTIC breasts. Balodis, Erin // Alive;Jul2014, Issue 381, p46 

    The article offers information on fibrocystic breasts that affects women aged to 30 to 50. Topics discussed include the physiology of fibrocystic breasts which is influenced by estrogen, progesterone and other hormones, symptoms and causes of fibrocystic breasts, the low risk for fibrocystic...

  • A life renewed in Tijuana. Bowra, Christin // Alive: Canada's Natural Health & Wellness Magazine;Aug2005, Issue 274, p118 

    Relates the author's experience who was diagnosed with Grave's disease and severe fibrocystic breast disease in Tijuana, Mexico. Medical history of the author; Set of treatments administered by a physician; Impact of the combination of regular allopathic medicine with traditional treatments on...

  • Evaluation of inadequate, indeterminate, false-negative and false-positive cases in cytological examination for breast cancer according to histological type. Rin Yamaguchi; Shin-ichi Tsuchiya; Takashi Koshikawa; Toshiro Yokoyama; Kuniko Mibuchi; Yasuhide Nonaka; Sonoe Ito; Hidejiro Higuchi; Mariko Nagao; Koichi Higaki; Jiro Watanabe; Masayoshi Kage; Hirohisa Yano // Diagnostic Pathology;2012, Vol. 7 Issue 1, p53 

    Background: We previously investigated the current status of breast cytology cancer screening at seven institutes in our area of southern Fukuoka Prefecture, and found some differences in diagnostic accuracy among the institutions. In the present study, we evaluated the cases involved and noted...

  • Phew! 5 signs it's NOT cancer. Kane, Kristin // Self;Oct2004, Vol. 26 Issue 10, p100 

    Presents several signs of non-cancerous breast lumps. Characteristics of a cyst; Formation of cysts and patches due to hormone changes; Concept of fibroadenoma.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics